# Vanda Pharmaceuticals Inc. (VNDA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Vanda Pharmaceuticals Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/VNDA/mda/fy2025/): filed 2026-02-12; accession 0001628280-26-007460 (https://www.sec.gov/Archives/edgar/data/1347178/000162828026007460/vnda-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/VNDA/mda/fy2024/): filed 2025-02-14; accession 0001628280-25-005761 (https://www.sec.gov/Archives/edgar/data/1347178/000162828025005761/vnda-20241231.htm)
- [FY 2023 MD&A](/company/VNDA/mda/fy2023/): filed 2024-02-08; accession 0001628280-24-003785 (https://www.sec.gov/Archives/edgar/data/1347178/000162828024003785/vnda-20231231.htm)
- [FY 2022 MD&A](/company/VNDA/mda/fy2022/): filed 2023-02-09; accession 0001628280-23-002857 (https://www.sec.gov/Archives/edgar/data/1347178/000162828023002857/vnda-20221231.htm)
- [FY 2021 MD&A](/company/VNDA/mda/fy2021/): filed 2022-02-24; accession 0001628280-22-003629 (https://www.sec.gov/Archives/edgar/data/1347178/000162828022003629/vnda-20211231.htm)

Back to /company/VNDA/